✦ LIBER ✦

Thrombotic microangiopathy and intravenous immunoglobulin therapy

✍ Scribed by Toru Watanabe

Publisher: Springer
Year: 2007
Tongue: English
Weight: 51 KB
Volume: 22
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-007-0441-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous gamma globulin for thromboti

Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology

✍ Shuichi Ito; Kenichi Okuyama; Tomoko Nakamura; Jun-ichi Tetanishi; Kazuo Saito; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 182 KB

Gemcitabine-associated thrombotic microa

Gemcitabine-associated thrombotic microangiopathy

✍ Benjamin D. Humphreys; Jeff P. Sharman; Joel M. Henderson; Jeffrey W. Clark; Pet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract ## BACKGROUND Gemcitabine‐associated thrombotic microangiopathy (TMA) is believed to be very rare, with an estimated incidence rate of 0.015%. Indications for gemcitabine are expanding, and comprehensive characterization of this complication is therefore important. ## METHODS The aut

Doxycycline, gastrointestinal bleeding,

Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy

✍ Hassane Izzedine; Vincent Launay-Vacher; Lucille Mercadal; Jean-Paul Vernant; Gi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Pathogenesis and prognosis of thrombotic

Pathogenesis and prognosis of thrombotic microangiopathy

✍ Masaomi Nangaku; Hiroshi Nishi; Toshiro Fujita 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 208 KB

Subacute (acute, persistent) thrombotic

Subacute (acute, persistent) thrombotic microangiopathy

✍ Edwin G. Taft; Bala B. Carver 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

## Abstract Six patients with prolonged acute courses of thrombotic microangiopathy are reviewed. These patients had in common courses of acute disease requiring plasma support for more than 3 months, with subsequent complete remission. Plasma support requirements may be prodigious, and the acute c

Intravenous immunoglobulin therapy: New

Intravenous immunoglobulin therapy: New aspects and outlook

✍ Imbach, P. ;Barandun, S. ;Baumgartner, Ch. ;Gaedicke, G. ;Hirt, A. ;Wagner, H. P 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 220 KB

Experiences gathered while exploring the usefulness of intravenous immunoglobulin for children with idiopathic (immune) thrombocytopenic purpura (ITP) are reviewed in view of further investigations characterizing the effects of IgG i.v. in other immune diseases without detectable antibody deficiency